Physician

Cristina N. Porch-Curren, M.D.

According to 2025 Medicare claims, Cristina Porch-Curren, M.D. (NPI: 1053314724) practices allergy/immunology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is ALLERGY CARE CENTER A MEDICAL CORPORATION (NPI: 1396781894; TIN: 77-0568817) and primary practice location at 93010-2379.

Porch-Curren's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 729 traditional Medicare patients, billed 80,180 HCPCS/CPT codes, and received $1,617,962 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,774 prescription claims across 515 beneficiaries totaling $1,625,264 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 429 claims. Open Payments data shows 153 records totaling $3,652. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $166,601 to $1,617,962. Similarly, Part D prescription costs have moved sharply higher in recent years, from $197,287 to $1,625,264. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $616 to $7,795.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$809K$1.6M2015 Medicare payment: $166,601 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $192,405 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $394,268 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $582,195 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $593,047 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $633,115 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $631,864 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $984,934 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,427,596 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,617,962 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152309,074$166,601
201627811,353$192,405
201735420,319$394,268
201840627,077$582,195
201935225,454$593,047
202035626,892$633,115
202147128,214$631,864
202264142,228$984,934
202370065,281$1,427,596
202472980,180$1,617,962

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$813K$1.6M2015 Drug cost: $197,287 (USD; Tot_Drug_Cst)2016 Drug cost: $196,633 (USD; Tot_Drug_Cst)2017 Drug cost: $219,376 (USD; Tot_Drug_Cst)2018 Drug cost: $362,026 (USD; Tot_Drug_Cst)2019 Drug cost: $611,908 (USD; Tot_Drug_Cst)2020 Drug cost: $574,046 (USD; Tot_Drug_Cst)2021 Drug cost: $801,368 (USD; Tot_Drug_Cst)2022 Drug cost: $955,660 (USD; Tot_Drug_Cst)2023 Drug cost: $1,471,938 (USD; Tot_Drug_Cst)2024 Drug cost: $1,625,264 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015122679$197,287
2016134850$196,633
20171691,070$219,376
20181771,155$362,026
20192021,311$611,908
20202041,232$574,046
20212731,533$801,368
20223481,835$955,660
20234633,022$1,471,938
20245153,774$1,625,264

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$240K$480K2016 Medicare payment: $69,706 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $52,121 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $57,508 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $57,520 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $111,502 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $161,716 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $287,216 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $365,528 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $480,144 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R24$69,706
2017N/R49$52,121
2018N/R67$57,508
2019N/R87$57,520
2020N/R140$111,502
2021N/R167$161,716
2022N/R251$287,216
202339384$365,528
202433429$480,144

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more143143$133
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more354590$103
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more434947$73
94010Test to measure expiratory airflow and volume280633$23
96160Administration and interpretation of patient-focused health risk assessment289941$3

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28911,534$237,272
Dupixent SyringeDupilumab451,260$176,632
HizentraImmun Glob G(Igg)/Pro/Iga 0-5022616$166,446
XolairOmalizumab491,390$149,615
Dupixent PenDupilumab23644$134,561

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1559Injection, immune globulin (hizentra), 100 mgNN/R45$180,650
J1569Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mgNN/R41$130,836
J1555Injection, immune globulin (cuvitru), 100 mgNN/R25$116,932
J1558Injection, immune globulin (xembify), 100 mgNN/R13$34,641
Q2052Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)NN/R25$8,241

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.153$3,652GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Cristina N. Porch-Curren, M.D.?

Tedicare shows public-source Medicare data for Cristina N. Porch-Curren, M.D. (NPI 1053314724), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Cristina N. Porch-Curren, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Cristina N. Porch-Curren, M.D.?

Cristina N. Porch-Curren, M.D. is linked to ALLERGY CARE CENTER A MEDICAL CORPORATION (billing NPI 1396781894) in the available physician profile data.

Does Cristina N. Porch-Curren, M.D. have Open Payments data?

Cristina N. Porch-Curren, M.D. has 153 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.